EDESA BIOTECH, INC. (EDSA) Total liabilities 2016–2021
EDESA BIOTECH, INC. (EDSA) total liabilities at each fiscal year-end, per SEC filings.
$1.5MFY2021 · since FY2016: $623,644 → $1.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $1.5M | -7.7% |
| FY2020 | $1.7M | — |
| FY2018 | $183,820 | -42.7% |
| FY2017 | $320,947 | -48.5% |
| FY2016 | $623,644 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More EDSA financial trends
EDSA RevenueEDSA Net incomeEDSA Net marginEDSA Gross profitEDSA Gross marginEDSA Operating incomeEDSA Operating marginEDSA Operating cash flowEDSA Free cash flowEDSA Capital expendituresEDSA Return on equityEDSA Stock buybacksEDSA Dividends paidEDSA Total assetsEDSA Shareholders’ equityEDSA overview →